Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bast

Showing results (41-50 of 560) with videos related to

Pageof 56
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2007
How do you distinguish a malignant pelvic mass from a benign pelvic mass? Imaging, biomarkers, or none of the aboveRichard G Moore, Robert C Bast
Biomarkers in Medicine|May 19, 2010
Early detection of ovarian cancerPartha M Das, Robert C Bast
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 1985
Use of the CA 125 antigen in diagnosis and monitoring of ovarian carcinomaR C Bast, R C Knapp
Cancers|September 22, 2019
Reply to Comment on "Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer" <i>Cancers</i> 2019, <i>11</i>, 596: Markers for Early Detection of Ovarian CancerJing Guo, Zhen Lu, Robert C Bast
Obstetrical & Gynecological Survey|September 11, 1990
The role of tumor markers in gynecologic oncologyG Olt, A Berchuck, R C Bast
Journal of the National Cancer Institute|April 25, 1992
Malignant transformation of ovarian epitheliumR C Bast, I Jacobs, A Berchuck
Cancers|March 6, 2021
Circulating Cancer BiomarkersAnna Lokshin, Robert C Bast, Karin Rodland
Expert Review of Molecular Diagnostics|May 5, 2017
The role of biomarkers in the management of epithelial ovarian cancerWei-Lei Yang, Zhen Lu, Robert C Bast
Seminars in Surgical Oncology|January 1, 1990
Gynecologic tumor markersG J Olt, A Berchuck, R C Bast
Cancer|October 31, 2014
How will we recruit, train, and retain physicians and scientists to conduct translational cancer research?Curtis R Pickering, Robert C Bast, Khandan Keyomarsi
Pageof 56

Showing results (41-50 of 560) with videos related to

Sort By:
Pageof 56
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2007
How do you distinguish a malignant pelvic mass from a benign pelvic mass? Imaging, biomarkers, or none of the aboveRichard G Moore, Robert C Bast
Biomarkers in Medicine|May 19, 2010
Early detection of ovarian cancerPartha M Das, Robert C Bast
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 1985
Use of the CA 125 antigen in diagnosis and monitoring of ovarian carcinomaR C Bast, R C Knapp
Cancers|September 22, 2019
Reply to Comment on "Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer" <i>Cancers</i> 2019, <i>11</i>, 596: Markers for Early Detection of Ovarian CancerJing Guo, Zhen Lu, Robert C Bast
Obstetrical & Gynecological Survey|September 11, 1990
The role of tumor markers in gynecologic oncologyG Olt, A Berchuck, R C Bast
Journal of the National Cancer Institute|April 25, 1992
Malignant transformation of ovarian epitheliumR C Bast, I Jacobs, A Berchuck
Cancers|March 6, 2021
Circulating Cancer BiomarkersAnna Lokshin, Robert C Bast, Karin Rodland
Expert Review of Molecular Diagnostics|May 5, 2017
The role of biomarkers in the management of epithelial ovarian cancerWei-Lei Yang, Zhen Lu, Robert C Bast
Seminars in Surgical Oncology|January 1, 1990
Gynecologic tumor markersG J Olt, A Berchuck, R C Bast
Cancer|October 31, 2014
How will we recruit, train, and retain physicians and scientists to conduct translational cancer research?Curtis R Pickering, Robert C Bast, Khandan Keyomarsi
Pageof 56